1-800-887-8100
COPAXONE® (glatiramer acetate injection) 40 mg/mL Logo
DOWNLOAD PRESCRIPTION & SERVICE REQUEST FORM (PSR)
MENU
Shared Solutions®
DOWNLOAD PRESCRIPTION & SERVICE REQUEST FORM (PSR)
Copaxone® is the #1 prescribed brand for relapsing MS in the US 1*

Clinical Nurse Educators —
Your partners for patient support

Teva’s Clinical Nurse Educators (CNEs) offer personalized services and support for you, your patients, and the RMS community

Teva’s Shared Solutions® offers in-person support from dedicated Clinical Nurse Educators (CNEs) who focus on educating patients about RMS and COPAXONE® therapy, and offer support through injection training and patient programs. These committed professionals partner with you in order to keep your patients feeling cared for and on track throughout their therapy.

Injection Training Icon

INJECTION
TRAINING

  • Increased patient confidence in managing injections

  • Reinforce proper injection technique

  • Personal injection plans to help patients achieve therapy goals

  • Personalized overall support

  • Free, in-home injection and refresher training available at any point to reinforce patient motivation

Health Care Provider Support Icon

HEALTHCARE
PROVIDER SUPPORT

  • High-level support to encourage patient adherence

  • Follow-up reporting on patient progress

  • Direct connection to Teva’s Shared Solutions® resources and injection supplies

  • Increased access to training, education, and overall support for your patients

Community Education Icon

COMMUNITY
EDUCATION

  • Education and support programs that connect patients with RMS community and with each other

  • Connection to resources that aid compliance and adherence

  • Assistance in understanding available support resources and financial options

  • Personalized, one-on-one counseling to help patients understand the basics of RMS and injection training for COPAXONE®

CNEs can help with a wide range of COPAXONE® patients

Newly Diagnosed

NEWLY
DIAGNOSED

Existing and/or returning to COPAXONE® (glatiramer acetate injection) 40 mg/mL

EXISTING/
RETURNING TO COPAXONE®

At Risk of Non-Adherence

AT RISK OF
NON-ADHERENCE

See how a Teva CNE can help your patients and your practice —
Contact Teva’s Shared Solutions® at 1-800-887-8100 and press 1 for COPAXONE®

Teva provides downloadable tools and resources to help your patients manage their RMS
EXPLORE RESOURCES
The COPAXONE iTracker® 2.0 mobile app helps your patients manage their injections
FIND OUT MORE
In-home initial injection trainings help support patients' injection experience
Learn more

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

IMPORTANT SAFETY INFORMATION

COPAXONE® is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol.
Approximately 16% of patients exposed to COPAXONE® 20 mg per mL compared to 4% of those on placebo, and approximately 2% of

You are now leaving this website

The website you are about to visit does not belong to Teva Neuroscience, Inc. or follow the same terms of service. Some of these websites may also require a third-party account, subscription, or payment to view.

While we carefully choose which websites we link to, we cannot control any changes or actions made by them. As a result, Teva makes no warranties or representations of any kind as to the accuracy, currency, or completeness of the following site, nor any liability on their behalf.

Continue to site
×